EAM
IRON icon

Exome Asset Management’s Disc Medicine IRON Stock Holding History

Exome Asset Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-46,743
Closed -$3.71M – 73
2025
Q4 		$3.71M Sell
46,743
-14,613
-24% -$1.23M 1.83% 18
2025
Q3 		$4.05M Hold
61,356
– – 2.68% 11
2025
Q2 		$3.25M Sell
61,356
-300
-0.5% -$14.1K 2.95% 14
2025
Q1 		$3.06M Sell
61,656
-7,416
-11% -$412K 2.74% 13
2024
Q4 		$4.38M Buy
69,072
+4,556
+7% +$264K 3.29% 7
2024
Q3 		$3.17M Buy
64,516
+3,516
+6% +$165K 2.14% 18
2024
Q2 		$2.75M Buy
+61,000
New +$2.07M 2.45% 16

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return